PMID- 28570615 OWN - NLM STAT- MEDLINE DCOM- 20170926 LR - 20190208 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 12 IP - 6 DP - 2017 TI - Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. PG - e0178473 LID - 10.1371/journal.pone.0178473 [doi] LID - e0178473 AB - Recent studies report a prevalence of non-alcoholic fatty liver disease (NAFLD) of between 70% and 80% in patients with metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM). Nevertheless, it is not possible to differentiate between simple steatosis and non-alcoholic steatohepatitis (NASH) with non-invasive tests. The aim of this study was to differentiate between simple steatosis and NASH by liver biopsy in patients with hypertransaminasemia and MS or T2DM. Two hundred and fifteen patients with increased ALT levels and MS, and 136 patients at their first diagnosis of T2DM regardless of ALT values were consecutively admitted to a tertiary hepatology center between January 2004 and November 2014. Exclusion criteria were other causes of liver disease/ALT increase. Each patient underwent a clinical, laboratory and ultrasound evaluation, and a liver biopsy. Gender distribution, age, and body mass index were similar in the two groups of patients, whereas cholesterol levels, glycemia and blood pressure were significantly different between the two groups. The prevalence of NAFLD was 94.82% in MS patients and 100% in T2DM patients. NASH was present in 58.52% of MS patients and 96.82% of T2DM. Consequently, this study reveals that, by using liver biopsy, almost all patients with T2DM or MS have NAFLD, which in patients with T2DM means NASH. Importantly, it suggests that NASH may be one of the early complications of T2DM due to its pathophysiological correlation with insulin resistance. FAU - Masarone, Mario AU - Masarone M AD - Internal Medicine and Hepatology Unit, University of Salerno, Salerno, Italy. FAU - Rosato, Valerio AU - Rosato V AD - Internal Medicine and Hepatology Department, University of Campania "L. Vanvitelli", Naples, Italy. FAU - Aglitti, Andrea AU - Aglitti A AD - Internal Medicine and Hepatology Unit, University of Salerno, Salerno, Italy. FAU - Bucci, Tommaso AU - Bucci T AD - Internal Medicine and Hepatology Unit, University of Salerno, Salerno, Italy. FAU - Caruso, Rosa AU - Caruso R AD - Internal Medicine and Hepatology Unit, University of Salerno, Salerno, Italy. FAU - Salvatore, Teresa AU - Salvatore T AD - Internal Medicine and Hepatology Department, University of Campania "L. Vanvitelli", Naples, Italy. FAU - Sasso, Ferdinando Carlo AU - Sasso FC AD - Internal Medicine and Hepatology Department, University of Campania "L. Vanvitelli", Naples, Italy. FAU - Tripodi, Marie Francoise AU - Tripodi MF AD - Internal Medicine and Hepatology Unit, University of Salerno, Salerno, Italy. FAU - Persico, Marcello AU - Persico M AUID- ORCID: 0000-0002-1399-6498 AD - Internal Medicine and Hepatology Unit, University of Salerno, Salerno, Italy. LA - eng PT - Journal Article DEP - 20170601 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Adult MH - Aged MH - Biopsy MH - Diabetes Mellitus, Type 2/*complications/pathology MH - Fatty Liver/complications/*pathology MH - Female MH - Humans MH - Liver/*pathology MH - Male MH - Middle Aged PMC - PMC5453539 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2017/06/02 06:00 MHDA- 2017/09/28 06:00 PMCR- 2017/06/01 CRDT- 2017/06/02 06:00 PHST- 2016/10/24 00:00 [received] PHST- 2017/05/13 00:00 [accepted] PHST- 2017/06/02 06:00 [entrez] PHST- 2017/06/02 06:00 [pubmed] PHST- 2017/09/28 06:00 [medline] PHST- 2017/06/01 00:00 [pmc-release] AID - PONE-D-16-42337 [pii] AID - 10.1371/journal.pone.0178473 [doi] PST - epublish SO - PLoS One. 2017 Jun 1;12(6):e0178473. doi: 10.1371/journal.pone.0178473. eCollection 2017.